Skip to content

Dose Reduction and Acquisition Parameters Optimization for PEDiatric Digital Radiography

Dose Reduction and Acquisition Parameters Optimization for PEDiatric Digital Radiography

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04007627
Acronym
DRAPOPED
Enrollment
200
Registered
2019-07-05
Start date
2019-07-15
Completion date
2019-08-31
Last updated
2019-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Radiology

Keywords

ALADA, IQ, Pediatric Radiology

Brief summary

To reduce As Low As Diagnostically Acceptable (ALADA) the X ray exposure of pediatric radiology by using a new post treatment processing algorithm (S-Vue, Samsung table GC85A).

Detailed description

The study will investigate the minimum dose required to obtain acceptable image quality for different pediatric localizations (abdomen, thorax, pelvis, spine) by using a simulation tool of different dose levels. Three different radiologists blinded to the simulated dose level will score the images independently by using a dedicated image quality scoring grid.

Interventions

None listed

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Children aged under 18 years and under 80 kg; * Prior radiography perfomed within 6 months before the beginning of the study.

Exclusion criteria

\- Refusal of parents to participate to the study.

Design outcomes

Primary

MeasureTime frameDescription
Assesment of image quality by radiologists blinded to the simulated dose levelthrough study completion, an average of 6 monthsThree different radiologists will score the images of localizations of abdomen, thorax, pelvis, spine independently by using a dedicated image quality scoring grid.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026